皮质醇/糖皮质激素受体:人排卵前卵泡排卵过程与黄素化的关键介质
本研究为实验性前瞻性临床与实验室研究,利用38例绝经前女性腹腔镜绝育术的优势卵泡及26例IVF女性的原代黄素化颗粒细胞,发现hCG上调糖皮质激素受体信号相关基因,RU486与CORT125281减少hCG诱导的孕酮和皮质醇生成并降低排卵相关基因表达,提示该信号通路调控人排卵前卵泡的类固醇生成与排卵级联。
要点
- hCG给药上调人排卵前卵泡及黄素化颗粒细胞中HSD11B1、NR3C1、FKBP5和FKBP4表达(P < 0.05)。
- RU486(20 µM)和CORT125281(50 µM)减少hCG诱导的黄素化颗粒细胞孕酮和皮质醇生成。
- RU486和/或CORT125281降低黄素化颗粒细胞中糖皮质激素受体信号、类固醇生成及关键排卵过程相关基因表达。
核心结论
- hCG诱导的糖皮质激素受体信号在人排卵前卵泡中调控类固醇生成和排卵级联反应,发挥关键作用。
研究设计与样本
- 实验性前瞻性临床与实验室研究,体内实验利用38例绝经前女性腹腔镜绝育术的优势卵泡。
- 体外实验利用26例绝经前女性IVF周期的原代黄素化颗粒细胞,研究于私人 fertility clinic 和学术医学中心进行。
主要发现
- hCG给药上调人排卵前卵泡和黄素化颗粒细胞中HSD11B1、NR3C1、FKBP5和FKBP4表达(P < 0.05)。
- RU486和CORT125281减少hCG诱导的黄素化颗粒细胞孕酮和皮质醇生成增加。
- RU486和/或CORT125281降低黄素化颗粒细胞中糖皮质激素受体信号、类固醇生成及关键排卵过程相关基因表达。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 利用黄素化颗粒细胞模型所展示的皮质醇/糖皮质激素受体作用可能不能完全反映其在体内的生理作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Do cortisol/glucocorticoid receptors play an active role in the human ovary during ovulation and early luteinization? SUMMARY ANSWER: The ovulatory hCG stimulation-induced glucocorticoid receptor signaling plays a crucial role in regulating steroidogenesis and ovulatory cascade in human periovulatory follicles. WHAT IS KNOWN ALREADY: Previous studies reported an increase in cortisol levels in the human follicular fluid after the LH surge or ovulatory hCG administration. However, little is known about the role of cortisol/glucocorticoid receptors in the ovulatory process and luteinization in humans. STUDY DESIGN, SIZE, DURATION: This study was an experimental prospective clinical and laboratory-based study. An in vivo experimental study was accomplished utilizing the dominant ovarian follicles from 38 premenopausal women undergoing laparoscopic sterilization. An in vitro experimental study was completed using the primary human granulosa/lutein cells (hGLC) from 26 premenopausal women undergoing IVF. PARTICIPANTS/MATERIALS, SETTING, METHODS: This study was conducted in a private fertility clinic and academic medical centers. Dominant ovarian follicles were collected before the LH surge and at defined times after hCG administration from women undergoing laparoscopic sterilization. Primary hGLC were collected from women undergoing IVF. hGLC were treated without or with hCG in the absence or presence of RU486 (20 µM; dual antagonist for progesterone receptor and glucocorticoid receptor) or CORT125281 (50 µM; selective glucocorticoid receptor antagonist) for 12 or 36 h. The expression of genes involved in glucocorticoid receptor signaling, steroidogenesis, and ovulatory cascade was studied with RT-quantitative PCR and western blotting. The production of cortisol, corticosterone, and progesterone was assessed by hormone assay kits. MAIN RESULTS AND THE ROLE OF CHANCE: hCG administration upregulated the expression of hydroxysteroid 11-beta dehydrogenase 1 (HSD11B1), nuclear receptor subfamily 3 group C member 1 (NR3C1), FKBP prolyl isomerase 5 (FKBP5), and FKBP prolyl isomerase 4 (FKBP4) in human ovulatory follicles and in hGLC (P < 0.05). RU486 and CORT125281 reduced hCG-induced increases in progesterone and cortisol production in hGLC. The expression of genes involved in glucocorticoid receptor signaling, steroidogenesis, and the key ovulatory process was reduced by RU486 and/or CORT125281 in hGLC. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: The role of cortisol/glucocorticoid receptors demonstrated using the hGLC model may not fully reflect their physiological roles in vivo. WIDER IMPLICATIONS OF THE FINDINGS: Successful ovulation and luteinization are essential for female fertility. Women with dysregulated cortisol levels often suffer from anovulatory infertility. Deciphering the functional role of glucocorticoid receptor signaling in human periovulatory follicles enhances our knowledge of basic ovarian physiology and may provide therapeutic insights into treating infertility in women. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by P01HD71875 (to M.J., T.E.C., and M.B.) and R01HD096077 (to M.J.) from the Foundation for the National Institutes of Health and the BTPSRF of the University of Kentucky Markey Cancer Center (P30CA177558). The authors report no competing interests. TRIAL REGISTRATION NUMBER: N/A.
引用
- Jeon H, Choi Y, Brännström M, et al. Cortisol/glucocorticoid receptor: a critical mediator of the ovulatory process and luteinization in human periovulatory follicles. Hum Reprod. 2023. PMID: 36752644. doi:10.1093/humrep/dead017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。